Neuroprotective agents for clinical trials in ALS: systematic assessment.
Burke
William J
WJ
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods*; D005069:Evaluation Studies as Topic; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care
D018696:Neuroprotective Agents